» Articles » PMID: 9261108

Production of a Specific Major Histocompatibility Complex Class I-restricted Epitope by Ubiquitin-dependent Degradation of Modified Ovalbumin in Lymphocyte Lysate

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1997 Aug 22
PMID 9261108
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Peptide epitopes presented through class I major histocompatability complex (MHC class I) on the cell surface, are generated by proteolytic processing of protein-antigens in the cytoplasm. The length and amino acid sequence determine whether a given peptide can fit into the peptide binding groove of class I heavy chain molecules and subsequently be presented to the immune system. The mode of action of the processing pathway is therefore of great interest. To study the processing mechanism of MHC class I-restricted intracellular antigens, we reconstituted the proteolytic processing of a model antigen in a cell-free system. Incubation of oxidized and urea-treated OVA in lymphocyte lysate resulted in partial degradation of the antigen. Degradation of the antigen depended on the presence of ATP. Addition of methylated ubiquitin abolished the reaction which was then restored by addition of an excess of native ubiquitin, indicating that the breakdown of the antigen in lymphocyte lysate is mediated by the ubiquitin proteolytic system. Upon incubation of modified OVA in lymphocyte lysate, a specific antigenic peptide was generated. The peptide was recognized by cytotoxic T lymphocytes directed against OVA-derived, H-2Kb-restricted peptide (SIINFEKL), and by a monoclonal antibody that recognizes cell-bound Kb-SIINFEKL complexes. Formation of the peptide epitope depended on the presence of ATP and ubiquitin. These results indicate that proteolytic processing of modified OVA is carried out by the ubiquitin-mediated degradation system. The experimental system described provides a tool to analyze the molecular mechanisms underlying the generation of specific, MHC class I-restricted peptide epitopes.

Citing Articles

Functional Differences between Proteasome Subtypes.

Abi Habib J, Lesenfants J, Vigneron N, Van den Eynde B Cells. 2022; 11(3).

PMID: 35159231 PMC: 8834425. DOI: 10.3390/cells11030421.


Proteasome subtypes and regulators in the processing of antigenic peptides presented by class I molecules of the major histocompatibility complex.

Vigneron N, Van den Eynde B Biomolecules. 2014; 4(4):994-1025.

PMID: 25412285 PMC: 4279167. DOI: 10.3390/biom4040994.


Study of antigen-processing steps reveals preferences explaining differential biological outcomes of two HLA-A2-restricted immunodominant epitopes from human immunodeficiency virus type 1.

Cohen W, Bianco A, Connan F, Camoin L, Dalod M, Lauvau G J Virol. 2002; 76(20):10219-25.

PMID: 12239297 PMC: 136577. DOI: 10.1128/jvi.76.20.10219-10225.2002.


Simultaneous binding of PA28 and PA700 activators to 20 S proteasomes.

Hendil K, Khan S, Tanaka K Biochem J. 1998; 332 ( Pt 3):749-54.

PMID: 9620878 PMC: 1219536. DOI: 10.1042/bj3320749.